Clinical Trial Protocol and Ethics Application
... A complete medical history will be recorded to obtain co-existing risk factor. The variables that will be obtained are as follows: 1. Baseline characteristics ...
... A complete medical history will be recorded to obtain co-existing risk factor. The variables that will be obtained are as follows: 1. Baseline characteristics ...
Fluid Overload: Diagnosis and Management
... seems appropriate to collect a series of contributions in which the reader can start with the information relevant to the type of syndromes involved in the observed clinical picture, to progress subsequently towards the pathophysiologic foundations of such syndromes, to further advance in the analys ...
... seems appropriate to collect a series of contributions in which the reader can start with the information relevant to the type of syndromes involved in the observed clinical picture, to progress subsequently towards the pathophysiologic foundations of such syndromes, to further advance in the analys ...
Guidelines for the diagnosis and treatment of pulmonary hypertension
... 7.4.4 Pulmonary arterial hypertension associated with portal hypertension .................................................................................................................... 28 Diagnosis ................................................................................................ ...
... 7.4.4 Pulmonary arterial hypertension associated with portal hypertension .................................................................................................................... 28 Diagnosis ................................................................................................ ...
Pulmonary Venous Anomalies
... failure to thrive. Cyanosis is mild because of adequate mixing of blood. Gradually they develop right heart failure and pulmonary arterial hypertension. Cardiac failure in most patients prior to 6 months of age. (Hepatomegaly is always present and peripheral edema is present in about half of the cas ...
... failure to thrive. Cyanosis is mild because of adequate mixing of blood. Gradually they develop right heart failure and pulmonary arterial hypertension. Cardiac failure in most patients prior to 6 months of age. (Hepatomegaly is always present and peripheral edema is present in about half of the cas ...
NIH Public Access - IUPUI ScholarWorks
... CONCLUSION—Beta-adrenergic stimulation and concomitant hypokalemia could cause nonischemic activation of IKATP, heterogeneous APD shortening and prolongation of CaiTD to provoke late phase 3 EAD, triggered activity and recurrent SVF. IKATP inhibition may be useful in managing ES during resistant hyp ...
... CONCLUSION—Beta-adrenergic stimulation and concomitant hypokalemia could cause nonischemic activation of IKATP, heterogeneous APD shortening and prolongation of CaiTD to provoke late phase 3 EAD, triggered activity and recurrent SVF. IKATP inhibition may be useful in managing ES during resistant hyp ...
Percutaneous Mitral Valve Therapy: The Next Decade
... they’re looking to transcatheter heart valve treatments to provide them. Transcatheter aortic valve implantation (TAVI) is already yielding almost $700 million in revenues (in OUS markets) where some 50,000 patients have undergone the procedure to date. Market estimates place the size of the TAVI ma ...
... they’re looking to transcatheter heart valve treatments to provide them. Transcatheter aortic valve implantation (TAVI) is already yielding almost $700 million in revenues (in OUS markets) where some 50,000 patients have undergone the procedure to date. Market estimates place the size of the TAVI ma ...
3D Echocardiography: A Review of the Current Status and Future
... and techniques offer superior image quality, greater accuracy, and expanding capabilities. As a result, more and improved imaging modalities are available for evaluating cardiac anatomy, ventricular function, blood flow velocity, and valvular diseases. Threedimensional (3D) echocardiography offers t ...
... and techniques offer superior image quality, greater accuracy, and expanding capabilities. As a result, more and improved imaging modalities are available for evaluating cardiac anatomy, ventricular function, blood flow velocity, and valvular diseases. Threedimensional (3D) echocardiography offers t ...
Health Technology Assessment Report 6 the Use of B Type
... List of figures Figure 4 - 1 Algorithm for assessment of suspected heart failure in primary care ..........................................................................................21 Figure 5 - 1 Pooled sensitivity of BNP for heart failure ................................32 Figure 5 - 2 Pool ...
... List of figures Figure 4 - 1 Algorithm for assessment of suspected heart failure in primary care ..........................................................................................21 Figure 5 - 1 Pooled sensitivity of BNP for heart failure ................................32 Figure 5 - 2 Pool ...
The ECGs that will be read around the world—and save lives of
... normal physiological adaptations in athletes from abnormal findings suggestive of pathology. On 13–14 February 2012, an international group of experts in sports cardiology and sports medicine convened in Seattle, Washington, to define contemporary standards for ECG interpretation in athletes. The obje ...
... normal physiological adaptations in athletes from abnormal findings suggestive of pathology. On 13–14 February 2012, an international group of experts in sports cardiology and sports medicine convened in Seattle, Washington, to define contemporary standards for ECG interpretation in athletes. The obje ...
Alternative Lead Systems for Diagnostic Electrocardiography
... The first electrocardiogram (ECG) in a human was recorded by Waller1 in 1887. He strapped a pair of electrodes on the front and back of the torso, or inserted the right hand and right foot into jars of salt solution, and connected an electrometer (an instrument that measured electrical potential). T ...
... The first electrocardiogram (ECG) in a human was recorded by Waller1 in 1887. He strapped a pair of electrodes on the front and back of the torso, or inserted the right hand and right foot into jars of salt solution, and connected an electrometer (an instrument that measured electrical potential). T ...
Congenital Aneurysm of the Sinus of Valsalva
... • Aneurysms usually arise from the right coronary sinus and extend into the right ventricle or right atrium. • Aneurysmal rupture into the right heart results in a large left-to-right shunt , which, in turn, can lead to congestive heart failure. • Unruptured aneurysms extending into the right heart ...
... • Aneurysms usually arise from the right coronary sinus and extend into the right ventricle or right atrium. • Aneurysmal rupture into the right heart results in a large left-to-right shunt , which, in turn, can lead to congestive heart failure. • Unruptured aneurysms extending into the right heart ...
Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin
... imaging showed significantly reduced diastolic circumferential strain (Ecc) rate in the HFD mice compared with controls (5.00.3 1/s versus 7.40.5 1/s, P<0.05), indicating diastolic dysfunction in the HFD mice. Systolic function was comparable in both groups (left ventricular ejection fraction=66.4 ...
... imaging showed significantly reduced diastolic circumferential strain (Ecc) rate in the HFD mice compared with controls (5.00.3 1/s versus 7.40.5 1/s, P<0.05), indicating diastolic dysfunction in the HFD mice. Systolic function was comparable in both groups (left ventricular ejection fraction=66.4 ...
Guidelines for the diagnosis and treatment of pulmonary hypertension
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
Guidelines for the diagnosis and treatment of pulmonary hypertension
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
Ventricular structure, function, and mechanics at high altitude
... Due to the unique arrangement of myofibers, cardiac form and function are intrinsically linked, as reflected in the cardiac mechanics (LV twist and rotation and ventricular strain) that underpin ventricular function. In response to altered physiological demand, ventricular mechanics acutely change ( ...
... Due to the unique arrangement of myofibers, cardiac form and function are intrinsically linked, as reflected in the cardiac mechanics (LV twist and rotation and ventricular strain) that underpin ventricular function. In response to altered physiological demand, ventricular mechanics acutely change ( ...
Patent Ductus Arteriosus - La Trobe Nursing
... PDA in the preterm infant Individual approach required – disease staging: • What is the infant’s gestational age? the lower gestation, the higher the risk for PDA • How old is the infant? increasing age decreases likelihood of treatment success requires early diagnosis -> requires early echo ...
... PDA in the preterm infant Individual approach required – disease staging: • What is the infant’s gestational age? the lower gestation, the higher the risk for PDA • How old is the infant? increasing age decreases likelihood of treatment success requires early diagnosis -> requires early echo ...
A Guide For Patients: Patent Foramen Ovale
... Rather than open-heart surgery, a PFO closure procedure does not involve incisions in the chest, the heart being stopped, or the prolonged recovery needed after open-heart surgery. Rather the heart is reached via the insertion of catheters typically in a leg vein, maneuvered to the heart, and then u ...
... Rather than open-heart surgery, a PFO closure procedure does not involve incisions in the chest, the heart being stopped, or the prolonged recovery needed after open-heart surgery. Rather the heart is reached via the insertion of catheters typically in a leg vein, maneuvered to the heart, and then u ...
Recurrent Cough Syncope Due to Pertussis in Adults
... Until yet, only six cases of cough syncope related to pertussis have been described in the medical literature [4, 7-10], two of which were not documented by laboratory tests for pertussis [10]. In our medical center, we have the national center for pertussis research and diagnosis, and we are strong ...
... Until yet, only six cases of cough syncope related to pertussis have been described in the medical literature [4, 7-10], two of which were not documented by laboratory tests for pertussis [10]. In our medical center, we have the national center for pertussis research and diagnosis, and we are strong ...
Increased Susceptibility of the Heart to Ventricular Fibrillation During
... during the period of hypercapnia. The arrhythmia did occur, however, in the immediate posthypercapneic period if the carbon dioxide tension was lowered suddenly to normal. This information suggests that a change in the plasma potassium concentration, when it occurs in the course of acid-base imbalan ...
... during the period of hypercapnia. The arrhythmia did occur, however, in the immediate posthypercapneic period if the carbon dioxide tension was lowered suddenly to normal. This information suggests that a change in the plasma potassium concentration, when it occurs in the course of acid-base imbalan ...
Perioperative Assessment of Diastolic Dysfunction
... higher readmission rate and postoperative mortality than those without this history (Table 1).16 Although TEE has been used extensively during noncardiac surgery, its use for assessment of perioperative diastolic function is limited.17 In a prospective observational study of patients undergoing vasc ...
... higher readmission rate and postoperative mortality than those without this history (Table 1).16 Although TEE has been used extensively during noncardiac surgery, its use for assessment of perioperative diastolic function is limited.17 In a prospective observational study of patients undergoing vasc ...
Guidelines for the diagnosis and treatment of pulmonary hypertension
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
... due to liver toxicity. Sitaxentan was withdrawn in December 2010 (for further information please see Eur Heart J 2011;32:386 – 387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arterial-hypertension.aspx). The instances where sitaxentan appears in t ...
ACC/AHA/NASPE Guideline for Implantation of Cardiac Pacemakers
... – Experts from ACC and AHA – Representatives from: NASPE, ACP, STS – University-affiliated and practicing physicians • Process: A formal literature review and evaluation of evidence • Procedures and treatments are classified by usefulness and efficacy Gregoratos G. et al. ACC/AHA/NASPE 2002 guidelin ...
... – Experts from ACC and AHA – Representatives from: NASPE, ACP, STS – University-affiliated and practicing physicians • Process: A formal literature review and evaluation of evidence • Procedures and treatments are classified by usefulness and efficacy Gregoratos G. et al. ACC/AHA/NASPE 2002 guidelin ...
diastolic-murmurs
... Mid diastolic and/or presystolic Low pitched best heard with bell Heavy jet of aortic regurgitation impinging on the anterior leaflet of mitral valve preventing adequate opening of the valve and creating turbulence to flow from left atrium to ventricle in diastole with premature closure of mitral va ...
... Mid diastolic and/or presystolic Low pitched best heard with bell Heavy jet of aortic regurgitation impinging on the anterior leaflet of mitral valve preventing adequate opening of the valve and creating turbulence to flow from left atrium to ventricle in diastole with premature closure of mitral va ...
Coronary artery disease
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), atherosclerotic heart disease, atherosclerotic cardiovascular disease, and coronary heart disease, is a group of diseases that includes: stable angina, unstable angina, myocardial infarction, and sudden coronary death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and gets better with rest. Shortness of breath may also occur and sometimes no symptoms are present. The first sign is occasionally a heart attack. Other complications include heart failure or an irregular heartbeat.Risk factors include: high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol, among others. Other risks include depression. The underlying mechanism involves atherosclerosis of the arteries of the heart. A number of tests may help with diagnoses including: electrocardiogram, cardiac stress testing, coronary computed tomographic angiography, and coronary angiogram, among others.Prevention is by eating a healthy diet, regular exercise, maintaining a healthy weight and not smoking. Sometimes medication for diabetes, high cholesterol, or high blood pressure are also used. There is limited evidence for screening people who are at low risk and do not have symptoms. Treatment involves the same measures as prevention. Additional medications such as antiplatelets including aspirin, beta blockers, or nitroglycerin may be recommended. Procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) may be used in severe disease. In those with stable CAD it is unclear if PCI or CABG in addition to the other treatments improve life expectancy or decreases heart attack risk.In 2013 CAD was the most common cause of death globally, resulting in 8.14 million deaths (16.8%) up from 5.74 million deaths (12%) in 1990. The risk of death from CAD for a given age has decreased between 1980 and 2010 especially in the developed world. The number of cases of CAD for a given age has also decreased between 1990 and 2010. In the United States in 2010 about 20% of those over 65 had CAD, while it was present in 7% of those 45 to 64, and 1.3% of those 18 to 45. Rates are higher among men than women of a given age.